HEADER NUCLEAR PROTEIN 03-NOV-22 8HD3 TITLE FARNESOID X RECEPTOR AGONISTS_FXR FUSED WITH A HD3 PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: FARNESOID X RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS BILE ACID RECEPTOR, AGONIST, FARNESOID X-ACTIVATED RECEPTOR, NUCLEAR KEYWDS 2 PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR X.LU,H.ZHANG REVDAT 1 08-NOV-23 8HD3 0 JRNL AUTH X.LU,H.ZHANG JRNL TITL CRYSTAL STRUCTURE OF FXR FUSED WITH A HD3 PEPTIDE IN COMPLEX JRNL TITL 2 WITH AGONIST QT0127 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.29 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.16_3549 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.29 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 55.40 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 27775 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.208 REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.110 REMARK 3 FREE R VALUE TEST SET COUNT : 1418 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 36.9300 - 4.9400 0.98 2729 160 0.1825 0.2247 REMARK 3 2 4.9400 - 3.9200 1.00 2677 147 0.1685 0.1734 REMARK 3 3 3.9200 - 3.4200 0.96 2530 137 0.1979 0.2686 REMARK 3 4 3.4200 - 3.1100 1.00 2659 145 0.2239 0.3098 REMARK 3 5 3.1100 - 2.8900 1.00 2645 140 0.2412 0.2615 REMARK 3 6 2.8900 - 2.7200 1.00 2656 132 0.2417 0.3017 REMARK 3 7 2.7200 - 2.5800 1.00 2628 120 0.2424 0.3318 REMARK 3 8 2.5800 - 2.4700 1.00 2597 157 0.2508 0.3298 REMARK 3 9 2.4700 - 2.3700 1.00 2656 140 0.2479 0.2955 REMARK 3 10 2.3700 - 2.2900 1.00 2580 140 0.2581 0.3317 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.291 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.140 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 42.67 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 4128 REMARK 3 ANGLE : 0.951 5584 REMARK 3 CHIRALITY : 0.048 623 REMARK 3 PLANARITY : 0.005 712 REMARK 3 DIHEDRAL : 4.797 2496 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8HD3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-NOV-22. REMARK 100 THE DEPOSITION ID IS D_1300033333. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-SEP-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL02U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97918 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 S 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27792 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.290 REMARK 200 RESOLUTION RANGE LOW (A) : 64.420 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 4.200 REMARK 200 R MERGE (I) : 0.06339 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.29 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.42 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.58770 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 4WVD. REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.97 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.56 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 50MM HEPES PH7.0, 3.5M SODIUM FORMATE, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 80.51600 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 17.20400 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 80.51600 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 17.20400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 247 REMARK 465 GLY A 248 REMARK 465 HIS A 249 REMARK 465 HIS A 250 REMARK 465 HIS A 251 REMARK 465 HIS A 252 REMARK 465 HIS A 253 REMARK 465 HIS A 254 REMARK 465 GLY A 255 REMARK 465 SER A 256 REMARK 465 THR A 257 REMARK 465 ASP A 506 REMARK 465 MET B 247 REMARK 465 GLY B 248 REMARK 465 HIS B 249 REMARK 465 HIS B 250 REMARK 465 HIS B 251 REMARK 465 HIS B 252 REMARK 465 HIS B 253 REMARK 465 HIS B 254 REMARK 465 GLY B 255 REMARK 465 SER B 256 REMARK 465 THR B 257 REMARK 465 SER B 487 REMARK 465 GLY B 488 REMARK 465 SER B 489 REMARK 465 GLY B 490 REMARK 465 LYS B 505 REMARK 465 ASP B 506 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 276 26.86 -71.81 REMARK 500 LEU A 405 52.84 -93.75 REMARK 500 ASP A 472 25.52 -74.14 REMARK 500 LYS B 390 56.37 38.89 REMARK 500 LEU B 405 49.76 -98.24 REMARK 500 REMARK 500 REMARK: NULL DBREF 8HD3 A 257 485 UNP Q96RI1 NR1H4_HUMAN 257 485 DBREF 8HD3 B 257 485 UNP Q96RI1 NR1H4_HUMAN 257 485 SEQADV 8HD3 MET A 247 UNP Q96RI1 INITIATING METHIONINE SEQADV 8HD3 GLY A 248 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 HIS A 249 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 HIS A 250 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 HIS A 251 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 HIS A 252 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 HIS A 253 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 HIS A 254 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 GLY A 255 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 SER A 256 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 ALA A 291 UNP Q96RI1 GLU 291 ENGINEERED MUTATION SEQADV 8HD3 ALA A 364 UNP Q96RI1 GLU 364 ENGINEERED MUTATION SEQADV 8HD3 GLY A 486 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 SER A 487 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 GLY A 488 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 SER A 489 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 GLY A 490 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 SER A 491 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 GLY A 492 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 SER A 493 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 GLY A 494 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 ASP A 495 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 HIS A 496 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 GLN A 497 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 LEU A 498 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 LEU A 499 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 ARG A 500 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 TYR A 501 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 LEU A 502 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 LEU A 503 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 ASP A 504 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 LYS A 505 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 ASP A 506 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 MET B 247 UNP Q96RI1 INITIATING METHIONINE SEQADV 8HD3 GLY B 248 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 HIS B 249 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 HIS B 250 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 HIS B 251 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 HIS B 252 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 HIS B 253 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 HIS B 254 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 GLY B 255 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 SER B 256 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 ALA B 291 UNP Q96RI1 GLU 291 ENGINEERED MUTATION SEQADV 8HD3 ALA B 364 UNP Q96RI1 GLU 364 ENGINEERED MUTATION SEQADV 8HD3 GLY B 486 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 SER B 487 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 GLY B 488 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 SER B 489 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 GLY B 490 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 SER B 491 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 GLY B 492 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 SER B 493 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 GLY B 494 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 ASP B 495 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 HIS B 496 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 GLN B 497 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 LEU B 498 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 LEU B 499 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 ARG B 500 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 TYR B 501 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 LEU B 502 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 LEU B 503 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 ASP B 504 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 LYS B 505 UNP Q96RI1 EXPRESSION TAG SEQADV 8HD3 ASP B 506 UNP Q96RI1 EXPRESSION TAG SEQRES 1 A 260 MET GLY HIS HIS HIS HIS HIS HIS GLY SER THR GLU LEU SEQRES 2 A 260 THR PRO ASP GLN GLN THR LEU LEU HIS PHE ILE MET ASP SEQRES 3 A 260 SER TYR ASN LYS GLN ARG MET PRO GLN GLU ILE THR ASN SEQRES 4 A 260 LYS ILE LEU LYS GLU ALA PHE SER ALA GLU GLU ASN PHE SEQRES 5 A 260 LEU ILE LEU THR GLU MET ALA THR ASN HIS VAL GLN VAL SEQRES 6 A 260 LEU VAL GLU PHE THR LYS LYS LEU PRO GLY PHE GLN THR SEQRES 7 A 260 LEU ASP HIS GLU ASP GLN ILE ALA LEU LEU LYS GLY SER SEQRES 8 A 260 ALA VAL GLU ALA MET PHE LEU ARG SER ALA GLU ILE PHE SEQRES 9 A 260 ASN LYS LYS LEU PRO SER GLY HIS SER ASP LEU LEU GLU SEQRES 10 A 260 ALA ARG ILE ARG ASN SER GLY ILE SER ASP GLU TYR ILE SEQRES 11 A 260 THR PRO MET PHE SER PHE TYR LYS SER ILE GLY GLU LEU SEQRES 12 A 260 LYS MET THR GLN GLU GLU TYR ALA LEU LEU THR ALA ILE SEQRES 13 A 260 VAL ILE LEU SER PRO ASP ARG GLN TYR ILE LYS ASP ARG SEQRES 14 A 260 GLU ALA VAL GLU LYS LEU GLN GLU PRO LEU LEU ASP VAL SEQRES 15 A 260 LEU GLN LYS LEU CYS LYS ILE HIS GLN PRO GLU ASN PRO SEQRES 16 A 260 GLN HIS PHE ALA CYS LEU LEU GLY ARG LEU THR GLU LEU SEQRES 17 A 260 ARG THR PHE ASN HIS HIS HIS ALA GLU MET LEU MET SER SEQRES 18 A 260 TRP ARG VAL ASN ASP HIS LYS PHE THR PRO LEU LEU CYS SEQRES 19 A 260 GLU ILE TRP ASP VAL GLY SER GLY SER GLY SER GLY SER SEQRES 20 A 260 GLY ASP HIS GLN LEU LEU ARG TYR LEU LEU ASP LYS ASP SEQRES 1 B 260 MET GLY HIS HIS HIS HIS HIS HIS GLY SER THR GLU LEU SEQRES 2 B 260 THR PRO ASP GLN GLN THR LEU LEU HIS PHE ILE MET ASP SEQRES 3 B 260 SER TYR ASN LYS GLN ARG MET PRO GLN GLU ILE THR ASN SEQRES 4 B 260 LYS ILE LEU LYS GLU ALA PHE SER ALA GLU GLU ASN PHE SEQRES 5 B 260 LEU ILE LEU THR GLU MET ALA THR ASN HIS VAL GLN VAL SEQRES 6 B 260 LEU VAL GLU PHE THR LYS LYS LEU PRO GLY PHE GLN THR SEQRES 7 B 260 LEU ASP HIS GLU ASP GLN ILE ALA LEU LEU LYS GLY SER SEQRES 8 B 260 ALA VAL GLU ALA MET PHE LEU ARG SER ALA GLU ILE PHE SEQRES 9 B 260 ASN LYS LYS LEU PRO SER GLY HIS SER ASP LEU LEU GLU SEQRES 10 B 260 ALA ARG ILE ARG ASN SER GLY ILE SER ASP GLU TYR ILE SEQRES 11 B 260 THR PRO MET PHE SER PHE TYR LYS SER ILE GLY GLU LEU SEQRES 12 B 260 LYS MET THR GLN GLU GLU TYR ALA LEU LEU THR ALA ILE SEQRES 13 B 260 VAL ILE LEU SER PRO ASP ARG GLN TYR ILE LYS ASP ARG SEQRES 14 B 260 GLU ALA VAL GLU LYS LEU GLN GLU PRO LEU LEU ASP VAL SEQRES 15 B 260 LEU GLN LYS LEU CYS LYS ILE HIS GLN PRO GLU ASN PRO SEQRES 16 B 260 GLN HIS PHE ALA CYS LEU LEU GLY ARG LEU THR GLU LEU SEQRES 17 B 260 ARG THR PHE ASN HIS HIS HIS ALA GLU MET LEU MET SER SEQRES 18 B 260 TRP ARG VAL ASN ASP HIS LYS PHE THR PRO LEU LEU CYS SEQRES 19 B 260 GLU ILE TRP ASP VAL GLY SER GLY SER GLY SER GLY SER SEQRES 20 B 260 GLY ASP HIS GLN LEU LEU ARG TYR LEU LEU ASP LYS ASP HET XAW A 601 26 HET XAW B 601 26 HETNAM XAW [(3S,5S,7S)-ADAMANTAN-1-YL][4-(2-AMINO-5-CHLOROPHENYL) HETNAM 2 XAW PIPERAZIN-1-YL]METHANONE FORMUL 3 XAW 2(C21 H28 CL N3 O) FORMUL 5 HOH *17(H2 O) HELIX 1 AA1 THR A 260 LYS A 276 1 17 HELIX 2 AA2 PRO A 280 GLU A 290 1 11 HELIX 3 AA3 SER A 293 LEU A 319 1 27 HELIX 4 AA4 GLY A 321 LEU A 325 5 5 HELIX 5 AA5 ASP A 326 LYS A 353 1 28 HELIX 6 AA6 PRO A 355 ARG A 367 1 13 HELIX 7 AA7 SER A 372 GLU A 388 1 17 HELIX 8 AA8 THR A 392 LEU A 405 1 14 HELIX 9 AA9 ASP A 414 GLN A 437 1 24 HELIX 10 AB1 GLN A 442 THR A 456 1 15 HELIX 11 AB2 THR A 456 SER A 467 1 12 HELIX 12 AB3 SER A 467 ASP A 472 1 6 HELIX 13 AB4 THR A 476 TRP A 483 1 8 HELIX 14 AB5 GLY A 492 ASP A 495 5 4 HELIX 15 AB6 HIS A 496 ASP A 504 1 9 HELIX 16 AB7 THR B 260 LYS B 276 1 17 HELIX 17 AB8 ARG B 278 LYS B 286 1 9 HELIX 18 AB9 ILE B 287 LYS B 289 5 3 HELIX 19 AC1 SER B 293 LYS B 318 1 26 HELIX 20 AC2 GLY B 321 LEU B 325 5 5 HELIX 21 AC3 ASP B 326 LYS B 353 1 28 HELIX 22 AC4 PRO B 355 ARG B 367 1 13 HELIX 23 AC5 SER B 372 GLU B 388 1 17 HELIX 24 AC6 THR B 392 LEU B 405 1 14 HELIX 25 AC7 ASP B 414 GLN B 437 1 24 HELIX 26 AC8 GLN B 442 ASN B 471 1 30 HELIX 27 AC9 THR B 476 ASP B 484 1 9 HELIX 28 AD1 GLY B 492 ASP B 495 5 4 HELIX 29 AD2 HIS B 496 ASP B 504 1 9 CRYST1 161.032 34.408 110.830 90.00 91.32 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006210 0.000000 0.000144 0.00000 SCALE2 0.000000 0.029063 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009025 0.00000